Stephen Lam
Corporate Officer/Principal chez Omnitura Therapeutics, Inc.
Profil
Stephen Lam is a Professor at the University of British Columbia and the Chief Medical Officer-Pulmonology at Omnitura Therapeutics, Inc. He previously worked as the Chairman at BC Cancer Agency, Advisor at the University of Colorado and the National Cancer Institute, and as an Advisor at the US Department of Health & Human Services.
He also served as a Governor at The American College of Financial Services and as an Advisor at The University of Texas Southwestern Medical Center.
Postes actifs de Stephen Lam
| Sociétés | Poste | Début |
|---|---|---|
Omnitura Therapeutics, Inc.
 Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Corporate Officer/Principal | - |
| University of British Columbia | Corporate Officer/Principal | 18/09/2009 |
Anciens postes connus de Stephen Lam
| Sociétés | Poste | Fin |
|---|---|---|
| The American College of Financial Services | Directeur/Membre du Conseil | - |
| The University of Colorado | Corporate Officer/Principal | - |
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| US Department of Health & Human Services (DC) | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Omnitura Therapeutics, Inc.
Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Health Technology |
BC Cancer Agency
 BC Cancer Agency Medical/Nursing ServicesHealth Services BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada. | Health Services |
| US Department of Health & Human Services (DC) | Government |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
